BIVI 424B5: Shelf registration
BioVie Inc.
Filed with the SEC on · accession 0001520138-26-000450
BIVI filed a 424B5 (prospectus (offering)) with the SEC on Nov 4, 2026. The final terms of an offering of shares or bonds. The stock moved -22.5% by the first close after the filing.
Summary of the filing
BioVie Inc. filed an amendment to its prospectus supplement reducing the maximum amount of common stock it may offer and sell under its sales agreement with A.G.P. from up to $6,464,341 to up to $1,225,000.
Key details
How BIVI stock reacted
Close before
$1.73
Nov 3, 2026
First close after
-22.54%
$1.34
5 trading days
—
Since filing
-23.12%
$1.33
✦ Ask GOAX AI about this filing — what it means for BIVI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BIVI?
Click hereFrequently asked questions
What did BIVI file with the SEC on Nov 4, 2026?
BIVI filed a 424B5 (Shelf registration). BioVie Inc. filed an amendment to its prospectus supplement reducing the maximum amount of common stock it may offer and sell under its sales agreement with A.G.P. from up to $6,464,341 to up to $1,225,000.
What does a shelf registration mean for BIVI stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did BIVI stock react to this filing?
BIVI closed at $1.73 before the filing and $1.34 on Nov 4, 2026 (-22.54%).
Other BIVI SEC filings
- 8-K · Secondary offeringNov 6, 2026
- 10-Q · SEC filingNov 6, 2026
- 424B5 · Shelf registrationNov 5, 2026
- 424B5 · Secondary offeringNov 5, 2026
- DEF 14A · Board changeSep 28, 2026
- 424B5 · Secondary offeringSep 14, 2026
- 8-K · Secondary offeringSep 14, 2026
- S-1 · Secondary offeringAug 14, 2026
- 10-K · SEC filingAug 13, 2026
- 8-K · Fda approvalAug 6, 2026
Get alerts when BIVI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days